Lantern Pharma Inc. Shareholders' Equity
Lantern Pharma Inc. (LTRN) had Shareholders' Equity of -$3.22 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$3.22M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.45M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $6.53M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.59M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$3.22M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $3.45M 10-Q · filed 2026-08-14 |
| 2025-12-31 | $6.53M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $9.59M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $12.52M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $16.78M 10-Q · filed 2026-08-14 |
| 2024-12-31 | $21.19M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $26.60M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $30.93M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $35.77M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $40.91M 10-K · filed 2026-03-30 |
| 2023-09-30 | $45.41M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $48.26M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $52.58M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $56.04M 10-K · filed 2025-03-27 |
| 2022-09-30 | $59.03M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $61.08M 10-Q · filed 2023-11-08 |
| 2022-03-31 | $65.32M 10-Q · filed 2023-11-08 |
| 2021-12-31 | $71.57M 10-K · filed 2024-03-18 |
| 2021-09-30 | $75.73M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $79.61M 10-Q · filed 2022-11-07 |
| 2021-03-31 | $81.73M 10-Q · filed 2022-11-07 |
| 2020-12-31 | $19.70M 10-K · filed 2023-03-20 |
| 2020-09-30 | $21.57M 10-Q · filed 2021-11-01 |
| 2020-06-30 | $23.23M 10-Q · filed 2021-11-01 |
| 2020-03-31 | $536.47K 10-Q · filed 2021-11-01 |
| 2019-12-31 | $943.28K 10-K · filed 2022-03-10 |
| 2019-09-30 | $1.56M 10-Q · filed 2020-10-29 |
| 2019-06-30 | $1.12M 10-Q · filed 2020-10-29 |
| 2019-03-31 | $1.74M 10-Q · filed 2020-10-29 |
| 2018-12-31 | -$201.80K 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |